Bath & Body Works, Inc. $BBWI Shares Bought by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC increased its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 209.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,079 shares of the company’s stock after purchasing an additional 18,315 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Bath & Body Works were worth $811,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in BBWI. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in shares of Bath & Body Works during the 2nd quarter worth approximately $33,000. SVB Wealth LLC purchased a new position in Bath & Body Works in the first quarter valued at about $35,000. Geneos Wealth Management Inc. boosted its position in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC grew its holdings in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after purchasing an additional 481 shares during the last quarter. Finally, Parkside Financial Bank & Trust increased its position in shares of Bath & Body Works by 24.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,842 shares of the company’s stock valued at $55,000 after buying an additional 364 shares in the last quarter. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Down 1.7%

BBWI stock opened at $22.03 on Friday. The company has a market cap of $4.54 billion, a price-to-earnings ratio of 6.54, a PEG ratio of 0.86 and a beta of 1.53. The business has a fifty day simple moving average of $25.65 and a 200-day simple moving average of $28.61. Bath & Body Works, Inc. has a 52 week low of $21.71 and a 52 week high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.37. The firm had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The firm’s quarterly revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.37 earnings per share. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 5th. Stockholders of record on Friday, November 21st will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 21st. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. Bath & Body Works’s dividend payout ratio is presently 23.74%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Wall Street Zen cut shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Weiss Ratings reissued a “hold (c-)” rating on shares of Bath & Body Works in a research note on Wednesday, October 8th. Wells Fargo & Company reduced their target price on Bath & Body Works from $44.00 to $33.00 and set an “overweight” rating on the stock in a research note on Monday, October 27th. Citigroup dropped their price target on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating for the company in a research report on Tuesday, August 19th. Finally, UBS Group reduced their price objective on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a research report on Friday, August 29th. Ten analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $38.18.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.